BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 19701757)

  • 1. Outcome of pediatric renal tumor treated using the Japan Wilms Tumor Study-1 (JWiTS-1) protocol: a report from the JWiTS group.
    Oue T; Fukuzawa M; Okita H; Mugishima H; Horie H; Hata J; Saito M; Nozaki M; Chin M; Nakadate H; Hinotsu S; Koshinaga T; Kaneko Y; Kitano Y; Tanaka Y;
    Pediatr Surg Int; 2009 Nov; 25(11):923-9. PubMed ID: 19701757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome of renal tumors registered in Japan Wilms Tumor Study-2 (JWiTS-2): A report from the Japan Children's Cancer Group (JCCG).
    Koshinaga T; Takimoto T; Oue T; Okita H; Tanaka Y; Nozaki M; Tsuchiya K; Inoue E; Haruta M; Kaneko Y; Fukuzawa M
    Pediatr Blood Cancer; 2018 Jul; 65(7):e27056. PubMed ID: 29630767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors Influencing Overall Survival of Children, Adolescents, and Young Adults With High-risk Renal Tumors.
    Islam M; Saltzman AF; Amini A; Carrasco A; Cost NG
    Urology; 2018 Oct; 120():222-230. PubMed ID: 30076944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors responsible for stage III disease in patients with Wilms tumor enrolled in the JWiTS-2 study.
    Oue T; Fukumoto K; Souzaki R; Takimoto T; Koshinaga T;
    Pediatr Surg Int; 2019 Oct; 35(10):1095-1099. PubMed ID: 31396736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of pediatric renal tumor: Past and future trials of the Japan Wilms Tumor Study Group.
    Oue T; Fukuzawa M; Koshinaga T; Okita H; Nozaki M; Chin M; Kaneko Y; Tanaka Y; Haruta M; Tsuchiya K; Kuwajima S; Takimoto T
    Pediatr Int; 2015 Oct; 57(5):828-31. PubMed ID: 26267611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study.
    Dome JS; Cotton CA; Perlman EJ; Breslow NE; Kalapurakal JA; Ritchey ML; Grundy PE; Malogolowkin M; Beckwith JB; Shamberger RC; Haase GM; Coppes MJ; Coccia P; Kletzel M; Weetman RM; Donaldson M; Macklis RM; Green DM
    J Clin Oncol; 2006 May; 24(15):2352-8. PubMed ID: 16710034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anaplastic histology Wilms' tumors registered to the Japan Wilms' Tumor Study Group are less aggressive than that in the National Wilms' Tumor Study 5.
    Oue T; Koshinaga T; Takimoto T; Okita H; Tanaka Y; Nozaki M; Haruta M; Kaneko Y; Fukuzawa M;
    Pediatr Surg Int; 2016 Sep; 32(9):851-5. PubMed ID: 27473009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of patients with revised stage I clear cell sarcoma of kidney treated in National Wilms Tumor Studies 1-5.
    Kalapurakal JA; Perlman EJ; Seibel NL; Ritchey M; Dome JS; Grundy PE
    Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):428-31. PubMed ID: 22658515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bilateral Wilms tumors treated according to the Japan Wilms Tumor Study Group protocol.
    Oue T; Koshinaga T; Okita H; Kaneko Y; Hinotsu S; Fukuzawa M
    Pediatr Blood Cancer; 2014 Jul; 61(7):1184-9. PubMed ID: 24623612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of the SIOP 93-01/GPOH trial and study for the treatment of patients with unilateral nonmetastatic Wilms Tumor.
    Reinhard H; Semler O; Bürger D; Bode U; Flentje M; Göbel U; Gutjahr P; Leuschner I; Maass E; Niggli F; Scheel-Walter HG; Stöckle M; Thüroff JW; Tröger J; Weirich A; von Schweinitz D; Zoubek A; Graf N
    Klin Padiatr; 2004; 216(3):132-40. PubMed ID: 15175957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment strategy for children with Wilms tumor].
    Fukuzawa M
    Nihon Geka Gakkai Zasshi; 2005 Jul; 106(7):422-6. PubMed ID: 16045185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic significance of blastemal predominant histology in initially resected Wilms' tumors: a report from the Study Group for Pediatric Solid Tumors in the Kyushu Area, Japan.
    Kinoshita Y; Suminoe A; Inada H; Yagi M; Yanai F; Zaizen Y; Nishi M; Inomata Y; Kawakami K; Matsufuji H; Suenobu S; Handa N; Kohashi K; Oda Y; Hara T; Taguchi T
    J Pediatr Surg; 2012 Dec; 47(12):2205-9. PubMed ID: 23217877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of cyclophosphamide and etoposide on outcome of clear cell sarcoma of the kidney treated on the National Wilms Tumor Study-5 (NWTS-5).
    Seibel NL; Chi YY; Perlman EJ; Tian J; Sun J; Anderson JR; Ritchey ML; Thomas PR; Miser J; Kalapurakal JA; Grundy PE; Green DM
    Pediatr Blood Cancer; 2019 Jan; 66(1):e27450. PubMed ID: 30255545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group.
    Grundy PE; Breslow NE; Li S; Perlman E; Beckwith JB; Ritchey ML; Shamberger RC; Haase GM; D'Angio GJ; Donaldson M; Coppes MJ; Malogolowkin M; Shearer P; Thomas PR; Macklis R; Tomlinson G; Huff V; Green DM;
    J Clin Oncol; 2005 Oct; 23(29):7312-21. PubMed ID: 16129848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blastemal predominant type Wilms tumor in Japan: Japan Children's Cancer Group.
    Koshinaga T; Takimoto T; Okita H; Tanaka Y; Inoue E; Oue T; Nozaki M; Tsuchiya K; Haruta M; Kaneko Y; Fukuzawa M
    Pediatr Int; 2019 Apr; 61(4):351-357. PubMed ID: 30786111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant renal tumors in childhood: report of 54 cases treated at a single institution.
    Jaing TH; Hung IJ; Yang CP; Lai JY; Tseng CK; Chang TY; Hsueh C; Tsay PK
    Pediatr Neonatol; 2014 Jun; 55(3):175-80. PubMed ID: 24279977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relapse of unilateral favorable histology Wilms' tumor: significant clinicopathological factors.
    Aoba T; Urushihara N; Fukumoto K; Furuta S; Fukuzawa H; Mitsunaga M; Watanabe K; Yamoto M; Miyake H; Koyama M; Iwabuchi H; Koike J; Tatsunami S; Wakisaka M; Kitagawa H
    J Pediatr Surg; 2012 Dec; 47(12):2210-5. PubMed ID: 23217878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 20-year prospective study of Wilms tumor and other kidney tumors: a report from Hong Kong pediatric hematology and oncology study group.
    Chan CC; To KF; Yuen HL; Shing Chiang AK; Ling SC; Li CH; Cheuk DK; Li CK; Shing MM
    J Pediatr Hematol Oncol; 2014 Aug; 36(6):445-50. PubMed ID: 25050908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytopathology of uncommon malignant renal neoplasms in the pediatric age group.
    Radhika S; Bakshi A; Rajwanshi A; Nijhawan R; Das A; Kakkar N; Joshi K; Marwaha RK; Rao KL
    Diagn Cytopathol; 2005 May; 32(5):281-6. PubMed ID: 15830360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autologous Stem Cell Transplantation for Children With Renal Tumors, and Adults With Wilms Tumor: Retrospective Analysis of the Japanese Transplant Registry Unified Management Program.
    Kobayashi R; Inoue M; Takahashi Y; Kikuta A; Ogawa A; Koga Y; Koh K; Hashii Y; Hara J; Kato K; Tabuchi K; Matsumoto K
    J Pediatr Hematol Oncol; 2020 May; 42(4):251-255. PubMed ID: 32134841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.